← Back to Search

Probiotic

B. lactis HN019 for Influenza

Phase 3
Waitlist Available
Led By Mario Clerici, MD
Research Sponsored by Fonterra Research Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

To determine if prophylactic supplementation with B. lactis HN019 reduces the risk of developing physician- and laboratory-confirmed influenza infection at any time during the 12-week supplementation period.

Eligible Conditions
  • Influenza

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Influenza infection
Secondary outcome measures
Adverse event incidence
Symptom duration
Symptom severity

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: B. lactis HN019Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bifidobacterium lactis HN019
2009
Completed Phase 3
~100

Find a Location

Who is running the clinical trial?

Fonterra Research CentreLead Sponsor
8 Previous Clinical Trials
908 Total Patients Enrolled
DaniscoIndustry Sponsor
34 Previous Clinical Trials
3,169 Total Patients Enrolled
Sprim Advanced Life SciencesOTHER
34 Previous Clinical Trials
5,183 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
2010. "Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01258842.
All > Health > Cte
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top